WO2004020609A3 - Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection - Google Patents
Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection Download PDFInfo
- Publication number
- WO2004020609A3 WO2004020609A3 PCT/US2003/027401 US0327401W WO2004020609A3 WO 2004020609 A3 WO2004020609 A3 WO 2004020609A3 US 0327401 W US0327401 W US 0327401W WO 2004020609 A3 WO2004020609 A3 WO 2004020609A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pneumoniae
- polypeptides
- relates
- methods
- diagnosis
- Prior art date
Links
- 241000193998 Streptococcus pneumoniae Species 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 230000000890 antigenic effect Effects 0.000 abstract 2
- 150000007523 nucleic acids Chemical group 0.000 abstract 2
- 241000194017 Streptococcus Species 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000001900 immune effect Effects 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003268353A AU2003268353A1 (en) | 2002-08-30 | 2003-09-02 | Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40708202P | 2002-08-30 | 2002-08-30 | |
US60/407,082 | 2002-08-30 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2004020609A2 WO2004020609A2 (en) | 2004-03-11 |
WO2004020609A9 WO2004020609A9 (en) | 2004-05-13 |
WO2004020609A3 true WO2004020609A3 (en) | 2004-07-15 |
Family
ID=31978415
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/027401 WO2004020609A2 (en) | 2002-08-30 | 2003-09-02 | Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003268353A1 (en) |
WO (1) | WO2004020609A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA05008568A (en) | 2003-02-14 | 2005-11-04 | Pfizer Prod Inc | Triazolo-pyridines as anti-inflammatory compounds. |
WO2006048753A2 (en) * | 2004-11-05 | 2006-05-11 | Pharmacia & Upjohn Company Llc | Anti-bacterial vaccine compositions |
WO2006048757A2 (en) * | 2004-11-05 | 2006-05-11 | Pharmacia & Upjohn Company Llc | Anti-bacterial vaccine compositions |
US8722055B2 (en) * | 2006-09-27 | 2014-05-13 | St. Jude Children's Research Hospital | Synthetic Streptococcus pneumoniae vaccine |
GB0714963D0 (en) * | 2007-08-01 | 2007-09-12 | Novartis Ag | Compositions comprising antigens |
US8404457B2 (en) * | 2008-02-01 | 2013-03-26 | Sanofi Pasteur Limited | Assay for diagnosing Streptococcus pneumoniae |
WO2011008548A1 (en) | 2009-06-29 | 2011-01-20 | Genocea Biosciences, Inc. | Vaccines and compositions against streptococcus pneumoniae |
RU2589256C2 (en) | 2010-12-03 | 2016-07-10 | Санофи Пастер Лимитид | Compositions and methods for immunisation against streptococcus pneumoniae |
EP2665490B1 (en) | 2011-01-20 | 2020-03-04 | Genocea Biosciences, Inc. | Vaccines and compositions against streptococcus pneumoniae |
EP2817320A1 (en) * | 2012-02-24 | 2014-12-31 | Novartis AG | Pilus proteins and compositions |
EP3380118A4 (en) * | 2015-11-25 | 2019-07-17 | Wake Forest University Health Sciences | Pneumococcal inhibitory factor compositions and methods of use thereof |
WO2020056202A1 (en) * | 2018-09-12 | 2020-03-19 | Affinivax, Inc. | Multivalent pneumococcal vaccines |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6420135B1 (en) * | 1996-10-31 | 2002-07-16 | Human Genome Sciences, Inc. | Streptococcus pneumoniae polynucleotides and sequences |
-
2003
- 2003-09-02 AU AU2003268353A patent/AU2003268353A1/en not_active Abandoned
- 2003-09-02 WO PCT/US2003/027401 patent/WO2004020609A2/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6420135B1 (en) * | 1996-10-31 | 2002-07-16 | Human Genome Sciences, Inc. | Streptococcus pneumoniae polynucleotides and sequences |
Also Published As
Publication number | Publication date |
---|---|
WO2004020609A9 (en) | 2004-05-13 |
AU2003268353A1 (en) | 2004-03-19 |
AU2003268353A8 (en) | 2004-03-19 |
WO2004020609A2 (en) | 2004-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Liu et al. | Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates | |
O’Brien-Simpson et al. | An immune response directed to proteinase and adhesin functional epitopes protects against Porphyromonas gingivalis-induced periodontal bone loss | |
Moreland et al. | Working towards a group A streptococcal vaccine: report of a collaborative Trans-Tasman workshop | |
AU2001276619A1 (en) | Immunisation against chlamydia pneumoniae | |
DK0942983T3 (en) | Streptococcus pneumoniae antigens and vaccines | |
WO2000039299A3 (en) | Streptococcus antigens | |
US9795664B2 (en) | Vaccine against streptococcal infections based on recombinant proteins | |
WO2000076540A3 (en) | Streptococcus pneumoniae proteins and vaccines | |
US8795690B2 (en) | Protective proteins of S. agalactiae, combinations thereof and methods of using the same | |
WO1999042588A3 (en) | Group b streptococcus antigens | |
WO2004020609A3 (en) | Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection | |
AU5328299A (en) | Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine | |
De et al. | Purification and characterization of Streptococcus pneumoniae palmitoylated pneumococcal surface adhesin A expressed in Escherichia coli | |
WO2007005627A8 (en) | Tuberculosis antigen detection assays and vaccines | |
Pinitkiatisakul et al. | Immunisation of mice against neosporosis with recombinant NcSRS2 iscoms | |
WO2001081380A3 (en) | Immunogenic pneumococcal protein and vaccine compositions thereof | |
EP0826774A3 (en) | Staphylococcal Fab I enoyl-ACP reductase | |
Wang et al. | Evaluation of a tandem Chlamydia psittaci Pgp3 multiepitope peptide vaccine against a pulmonary chlamydial challenge in mice | |
ATE366583T1 (en) | IDENTIFICATION OF SPECIFIC DIFFERENTIALLY EXPRESSED ANTIGENS FROM MYCOBACTERIUM AND MEDICAL USE OF THE MYCOBACTERIUM PROTEINS RV0068 AND RV3407 | |
EP0846766A3 (en) | IgA Fc binding protein from Streptococcus pneumoniae | |
EP1219635A3 (en) | Chlamydia pneumoniae antigenes | |
KR20010020529A (en) | Compounds encoding the protective m-like protein of streptococcus equi and assays therefor | |
Loss | An Immune Response Directed to Proteinase | |
WO2003013601A1 (en) | Toxin associated with sudden infant death syndrome, and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
COP | Corrected version of pamphlet |
Free format text: PAGES 1/9-9/9, DRAWINGS, REPLACED BY NEW PAGES 1/11-11/11; DUE TO LATE TRANSMITTAL BY THE RECEIVINGOFFICE |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |